within Pharmacolibrary.Drugs.D_Dermatologicals.D01A_AntifungalsForTopicalUse.D01AE24_Tavaborole;

model Tavaborole
  extends Pharmacolibrary.Drugs.ATC.D.D01AE24;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>D01AE24</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Tavaborole is a topical antifungal agent used to treat onychomycosis (fungal infection of the toenails or fingernails) in adults. It acts by inhibiting leucyl-tRNA synthetase, thereby disrupting protein synthesis in fungal cells. It is an FDA-approved treatment for onychomycosis of the toenails caused by Trichophyton rubrum or Trichophyton mentagrophytes.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters estimated in healthy adults based on available FDA label and review information. No published studies report quantitative compartmental pharmacokinetic models for tavaborole in humans.</p><h4>References</h4><ol><li><p>Zane, LT, et al., &amp; Gupta, AK (2015). Tavaborole topical solution, 5% for the treatment of toenail onychomycosis. <i>Drugs of today (Barcelona, Spain : 1998)</i> 51(10) 599–607. DOI:<a href=\"https://doi.org/10.1358/dot.2015.51.10.2401004\">10.1358/dot.2015.51.10.2401004</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/26583302/\">https://pubmed.ncbi.nlm.nih.gov/26583302</a></p></li><li><p>Jinna, S, &amp; Finch, J (2015). Spotlight on tavaborole for the treatment of onychomycosis. <i>Drug design, development and therapy</i> 9 6185–6190. DOI:<a href=\"https://doi.org/10.2147/DDDT.S81944\">10.2147/DDDT.S81944</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/26640371/\">https://pubmed.ncbi.nlm.nih.gov/26640371</a></p></li><li><p>Elewski, BE, &amp; Tosti, A (2014). Tavaborole for the treatment of onychomycosis. <i>Expert opinion on pharmacotherapy</i> 15(10) 1439–1448. DOI:<a href=\"https://doi.org/10.1517/14656566.2014.921158\">10.1517/14656566.2014.921158</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/24856836/\">https://pubmed.ncbi.nlm.nih.gov/24856836</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Tavaborole;
